𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Insulin-like growth factor receptor 1 pathway signature correlates with adverse clinical outcome in ovarian cancer

✍ Scribed by B. Winterhoff; P. Haluska; K. Kalli; W. Cliby; B. Gostout; A. Oberg; M. Maurer; L. Hartmann; D. Slamon; G. Konecny

Book ID
113962895
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
108 KB
Volume
120
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin-like growth factor 1 expression
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan
✍ Mario Scartozzi; Alessandra Mandolesi; Riccardo Giampieri; Chiara Pierantoni; Fo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 245 KB

## Abstract Seventy to 40% of K‐RAS wild type colorectal tumors does not seem to benefit from treatment with antiepidermal growth factor receptor (anti‐EGFR) monoclonal antibodies. Recent data suggested that in presence of IGF‐1 system, altered activation colorectal cancer cells may escape anti‐EGF

Expression of insulin-like growth factor
Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status
✍ Jose A. Figueroa; James G. Jackson; William L. McGuire; Robert F. Krywicki; Doug 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 875 KB

The insulin-like growth factors (IGFs) have been implicated in the growth regulation of human breast cancer. Since the lCFs are associated with specific binding proteins (ICFBPs) which may modulate receptor/ligand interactions, production of IGFBPs by breast cancer cells could alter their IGF-depend

Heparin-binding epidermal growth factor-
Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome
✍ Christopher Kramer; Kai Klasmeyer; Hans Bojar; Wolfgang A. Schulz; Rolf Ackerman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

## Abstract ## BACKGROUND. Cleavage of membrane‐anchored heparin‐binding epidermal growth factor‐like growth factor (proHB‐EGF) yields a soluble HB‐EGF isoform (sHB‐EGF), which is an activating epidermal growth factor receptor (EGFR) ligand and a C‐terminal fragment HB‐EGF‐C acting directly in the